Human Immunodeficiency Virus Type 1 Recombinant Reverse Transcriptase Enzymes Containing the G190A and Y181C Resistance Mutations Remain Sensitive to Etravirine

Eitemau Tebyg

• The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity
  gan: Xu, Hong-Tao, et al.
  Cyhoeddwyd: (2010)
• Lamivudine Can Exert a Modest Antiviral Effect against Human Immunodeficiency Virus Type 1 Containing the M184V Mutation
  gan: Quan, Yudong, et al.
  Cyhoeddwyd: (2003)
• Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
  gan: Xu, Hong-Tao, et al.
  Cyhoeddwyd: (2013)
• Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes
  gan: Asahchop, Eugene L., et al.
  Cyhoeddwyd: (2011)
• Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1
  gan: Coutsinos, Dimitrios, et al.
  Cyhoeddwyd: (2009)